Xentria Revenue and Competitors
Estimated Revenue & Valuation
- Xentria's estimated annual revenue is currently $1.8M per year.
- Xentria's estimated revenue per employee is $100,500
Employee Data
- Xentria has 18 Employees.
- Xentria grew their employee count by 64% last year.
Xentria's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Finance | Reveal Email/Phone |
2 | VP Clinical Development | Reveal Email/Phone |
3 | VP Quality Assurance | Reveal Email/Phone |
4 | Associate Director Human Resources | Reveal Email/Phone |
5 | Director Clinical Operations | Reveal Email/Phone |
6 | Associate Director Clinical Operations | Reveal Email/Phone |
7 | Director, Clinical Research | Reveal Email/Phone |
8 | Director CMC, Clinical Supply | Reveal Email/Phone |
9 | Associate Director Clinical Operations-TMF | Reveal Email/Phone |
10 | Clinical Project Manager | Reveal Email/Phone |
Xentria Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 124 | 25% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 23 | -8% | N/A | N/A |
#7 | $6.6M | 17 | -37% | N/A | N/A |
#8 | $13.5M | 41 | -25% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 13 | -28% | N/A | N/A |
What Is Xentria?
Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.8M
Revenue (est)
64%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 18 | -5% | N/A |
#2 | $2.7M | 18 | N/A | N/A |
#3 | $0.5M | 18 | 13% | $2.5M |
#4 | $0.5M | 18 | 29% | $3.9M |
#5 | $2.2M | 18 | N/A | N/A |